Inventor · disambiguated record
Byungje Sung
Also filed as: SUNG BYUNGJE
7 granted patents·9 pending applications·10 citations·filing 2018–2024
77Inventor score
Top patents by PatentIndex Score
16 records- 0187US11707533B2Antibody-drug conjugate comprising antibody against human ROR1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2020·Granted Jul 25, 2023·2 cites·38 claims
- 0286US11891445B1Anti-B7-H3 antibody and use thereofABL BIO INC·Filed 2019·Granted Feb 6, 2024·5 cites·14 claims
- 0382US11261259B2Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereofI MAB BIOPHARMA US LTD·Filed 2020·Granted Mar 1, 2022·1 cites·19 claims
- 0476US2025115670A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 0575US12195537B2Anti-4-1BB antibody and use thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·4 claims
- 0673US12071483B1Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereofABL BIO INC·Filed 2018·Granted Aug 27, 2024·1 cites·18 claims
- 0770US2025059266A1Antibodies for treating alpha-synucleinopathiesABL BIO INCORPORATED·Filed 2024·Application pending·0 cites
- 0870US2023357412A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2022·Application pending·0 cites
- 0969US2023405139A1Antibody-drug conjugate comprising antibody against human ror1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1068US2024101687A1Bispecific Antibody to A-Syn/IGF1R and Use ThereofABL BIO INC·Filed 2023·Application pending·0 cites
- 1160US2022348665A1BISPECIFIC ANTIBODY AGAINST Alpha-SYN/IGF1R AND USE THEREOFABL BIO INC·Filed 2020·Application pending·0 cites
- 1260US2022380446A1Antibodies for treating alpha-synucleinopathiesABL BIO INCORPORATED·Filed 2022·Application pending·0 cites
- 1354US2025084158A1Anti-cll-1 antibodies and uses thereofABL BIO INC·Filed 2022·Application pending·0 cites
- 1447US12122830B1Anti-ROR1 antibody and use thereofABL BIO INC·Filed 2019·Granted Oct 22, 2024·0 cites·16 claims
- 1543US12049493B2Anti-alpha-synuclein antibodies and uses thereofABL BIO INC·Filed 2018·Granted Jul 30, 2024·0 cites·20 claims
- 1640US2023279085A1ANTIBODIES TO alpha-SYNUCLEIN AND USES THEREOFABL BIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Byungje Sung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →